ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1247

Relation of Measures of Pain Sensitization to Widespread Pain

ZHIQIANG WANG1, Sarah Tilley2, Laura Frey Law3, Cora Lewis4, Michael Nevitt5, Kosaku Aoyagi6, Chunyi Wen7, Changhai Ding1 and Tuhina Neogi8, 1Zhujiang Hospital, Southern Medical University, Guangzhou, China (People's Republic), 2Boston University School of Medicine, Somerville, MA, 3Department of Physical Therapy and Rehabilitation Science, Carver College of Medicine, University of Iowa, Iowa City, IA, 4The University of Alabama at Birmingham, Birmingham, AL, 5University of California, San Francisco, San Francisco, CA, 6University of Texas at El Paso, El Paso, TX, 7The Hong Kong Polytechnic University, Hong Kong, China (People's Republic), 8Boston University School of Medicine, Boston, MA

Meeting: ACR Convergence 2025

Keywords: Epidemiology, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1221–1247) Pain in Rheumatic Disease Including Fibromyalgia Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Widespread pain (WSP) is thought to be related to alterations in nociceptive signaling such as pain sensitization. Whether pain sensitization predisposes to an increase in number of pain sites, including the development of WSP, is not known.

Methods: We included participants from the Multicenter Osteoarthritis Study (MOST), a NIH-funded longitudinal cohort, who reported pain sites on a homunculus at baseline and two years later to determine WSP status (defined as pain above and below the waist, on the right and left sides of the body, and axially), and underwent quantitative sensory testing (QST). We assessed baseline pain sensitization (i.e., alterations in ascending nociceptive signaling) using three QST measures: temporal summation (TS) at the wrist, and pressure pain threshold (PPT) at the patella (average of both knees), and PPT at the wrist. Higher TS indicates more pain sensitization, while higher PPT indicates less pain sensitization. We analyzed the relations of QST to: 1) the presence of WSP at baseline; 2) an increase of at least two painful sites after two years of follow-up; and 3) incident WSP after two years among those who were free of WSP at baseline. We used logistic regression to estimate presence of WSP at baseline, and modified Poisson regression for the longitudinal analyses. We secondarily performed sex-stratified analyses given known sex differences in QST. All analyses were adjusted for potential confounders, including age, sex (for analyses of the whole sample), BMI, race, site, presence of symptomatic knee osteoarthritis in at least one knee, depressive symptoms, NSAID use, Opioid use, and Charlson comorbidity index.

Results: We included 3078 participants (mean age 62.7, 57.7% female), of whom 32.2% had WSP at baseline (67.8% female), and 23.5% had an increase in two or more painful sites (59.8% female) at two years of follow-up. Among the 2088 participants free of WSP at baseline (mean age 62.1, 52.9% female), 14.9% had incident WSP (55.9% female) over two years. Cross-sectionally, TS was significantly associated with baseline WSP in the whole sample and in females but not in males (Table). PPT at the wrist was inversely associated with baseline WSP in the whole sample and in both sexes, while PPT at the patella was inversely associated in the whole sample and female participants, but not in males (Table). There were no significant associations between QST measures and either an increase in at least two painful sites or incidence of WSP after two years of follow-up (Table).

Conclusion: Although QST measures were associated with WSP cross-sectionally, they were not associated with incident WSP or increase in number of pain sites over two years. However, the null longitudinal findings may have been limited by the phenomenon of depletion of susceptibles (i.e., those most susceptible had already developed WSP in relation to pain sensitization at an earlier age).

Supporting image 1Table. Associations between quantitative sensory testing measurements and widespread pain

§ TS Wrist additionally adjusted for study visit due to protocol change.

# Adjusted for the following potential confounders: age, sex (for whole sample), BMI, race, site, presence of symptomatic knee OA in at least one knee, depressive symptoms, NSAID use, Opioid use, and Charlson comorbidity index.

* Increase in at least two painful sites over 2 years additionally adjusted for baseline number of painful sites.

TS: higher values indicate more pain sensitization; PPT: lower values indicate more pain sensitization.

Abbreviations: TS, temporal summation; PPT, pressure pain threshold; SD, standard deviation; WSP, widespread pain; CI, confidence interval; OR, odds ratio; RR, risk ratio.


Disclosures: Z. WANG: None; S. Tilley: None; L. Frey Law: None; C. Lewis: None; M. Nevitt: None; K. Aoyagi: None; C. Wen: None; C. Ding: None; T. Neogi: None.

To cite this abstract in AMA style:

WANG Z, Tilley S, Frey Law L, Lewis C, Nevitt M, Aoyagi K, Wen C, Ding C, Neogi T. Relation of Measures of Pain Sensitization to Widespread Pain [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/relation-of-measures-of-pain-sensitization-to-widespread-pain/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relation-of-measures-of-pain-sensitization-to-widespread-pain/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology